News

Apretude is a long-acting injectable medication used for HIV pre-exposure prophylaxis (PrEP). Planned Parenthood will offer ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?
June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.
HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...
The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...
The Trump administration has lifted a freeze on federal funds for HIV prevention and surveillance programs, officials said, ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...
National HIV Testing Day has raised awareness and confront stereotypes about HIV. Learn about HIV testing options and ...
State's Health Outreach and Prevention program will end June 30 after federal funding cuts to HIV outreach and prevention ...